Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2020
Q1
Sell
-18,804
Closed -$406K 214
2019
Q4
$406K Sell
18,804
-34,600
-65% -$794K 0.02% 924
2019
Q3
$1.21M Buy
+53,404
New +$1.48M 0.06% 470
2019
Q2
Sell
-13,349
Closed -$421K 1371
2019
Q1
$421K Sell
13,349
-9,476
-42% -$276K 0.03% 810
2018
Q4
$574K Sell
22,825
-3,520
-13% -$90.4K 0.04% 664
2018
Q3
$760K Buy
+26,345
New +$493K 0.03% 690
2018
Q2
Sell
-23,226
Closed -$185K 1451
2018
Q1
$185K Buy
+23,226
New +$143K 0.01% 1283

Other funds holding CDNA

A.R.T. Advisors's CDNA Position: Q1 2020 in Review

A.R.T. Advisors sold out of CareDx (CDNA) in Q1 2020, closing a stake of 18,804 shares — an estimated $406K sold.

A.R.T. Advisors first reported a position in CDNA in Q1 2018 and held it in 6 quarters. The position peaked at $1.21M in Q3 2019. 144 funds tracked by Wall St. Rank hold CDNA as of Q1 2020.

  • A.R.T. Advisors reported no remaining CareDx position as of Q1 2020 after selling out during the quarter.
  • A.R.T. Advisors sold 18,804 CareDx shares in Q1 2020, an estimated $406K.
  • A.R.T. Advisors first reported a position in CareDx in Q1 2018 and held it in 6 quarters.
  • A.R.T. Advisors's CareDx position peaked at $1.21M in Q3 2019.
  • 144 funds tracked by Wall St. Rank held CareDx as of Q1 2020.

Based on A.R.T. Advisors's 13F filing for Q1 2020, filed 15 May 2020.